Synbio Tech (ROCO:1295) Debt-to-EBITDA : 3.30 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Synbio Tech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$30.1 Mil. Synbio Tech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$701.7 Mil. Synbio Tech's annualized EBITDA for the quarter that ended in Dec. 2023 was NT$221.8 Mil. Synbio Tech's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 3.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Synbio Tech's Debt-to-EBITDA or its related term are showing as below:

ROCO:1295' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.89 Med: 2.52 Max: 3.17
Current: 3.17

During the past 4 years, the highest Debt-to-EBITDA Ratio of Synbio Tech was 3.17. The lowest was 1.89. And the median was 2.52.

ROCO:1295's Debt-to-EBITDA is ranked worse than
69.63% of 270 companies
in the Biotechnology industry
Industry Median: 1.31 vs ROCO:1295: 3.17

Synbio Tech Debt-to-EBITDA Historical Data

The historical data trend for Synbio Tech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech Debt-to-EBITDA Chart

Synbio Tech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

1.90

1.89

3.13

3.17

Synbio Tech Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial			N/A	-	3.90	2.97	3.30

Competitive Comparison of Synbio Tech's Debt-to-EBITDA

For the Biotechnology subindustry, Synbio Tech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synbio Tech's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synbio Tech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Synbio Tech's Debt-to-EBITDA falls into.

Synbio Tech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Synbio Tech's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(30.069	+	701.697)	/	230.539
	=	3.17

Synbio Tech's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(30.069	+	701.697)	/	221.798
	=	3.30

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Synbio Tech (ROCO:1295) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Synbio Tech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Synbio Tech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Synbio Tech (ROCO:1295) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66,Beiling 6th Road, 821 Road, Luzhu District, Kaohsiung, TWN

Website

https://www.synbiotech.com

Synbio Tech Inc is a company specializing in the research, manufacturing and application development of lactic acid bacteria. They provide lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products , share application development technology, provide excellent service quality, and gain recognition from customers, allowing Shenghe to grow steadily.

Synbio Tech (ROCO:1295) Headlines

No Headlines